<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> secondary to <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> due to the rupture of an <z:hpo ids='HP_0004944'>intracranial aneurysm</z:hpo> has a high morbidity/mortality </plain></SENT>
<SENT sid="1" pm="."><plain>Its cause is still unknown, so we obtain controversial results after prevention and treatment </plain></SENT>
<SENT sid="2" pm="."><plain>We studied two groups, of 29 patients each one, where the first was treated with systemic nimodipine, and the second was the control group </plain></SENT>
<SENT sid="3" pm="."><plain>We did not observed any correlation between the clinic vasospasm or the symptomatic, and the radiographic one </plain></SENT>
<SENT sid="4" pm="."><plain>There was no difference between the final results of both groups </plain></SENT>
<SENT sid="5" pm="."><plain>No collateral effects were shown in other organs with the use of this agent </plain></SENT>
</text></document>